Characterization and analysis of polymorphs by near-infrared spectrometry

Analytica Chimica Acta

Volumn 502, Issue 2, 2004, Pages 221-227

  Blanco, M ^a   Valdes D ^a   Bayod, M S ^b   Fernandez Mari F ^b   Llorente, I ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Depto de Invest y Desarrollo   (Spain)

Author keywords

Analysis; Azithromycin; Multivariate calibration; Near infrared spectrometry; Partial least squares regression; Polymorphism

Indexed keywords

ABSORPTION; AMORPHOUS MATERIALS; CHARACTERIZATION; CRYSTALLINE MATERIALS; INFRARED SPECTROSCOPY; MOISTURE; REGRESSION ANALYSIS;

BIOAVAILABILITY; POLYMORPHIC PURITY;

DRUG PRODUCTS;

AZITHROMYCIN;

ARTICLE; CALIBRATION; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DRUG DETERMINATION; DRUG FORMULATION; MOISTURE; NEAR INFRARED SPECTROSCOPY; PRIORITY JOURNAL; REGRESSION ANALYSIS; VALIDATION PROCESS;

EID: 0345802671     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2003.10.016     Document Type: Article

References (20)

1. D.J.W. Grant, Theory and origin of polymorphism, in: H.G. Britain, Polymorphism in Pharmaceutical Solids, Dekker (Marcel), New York, 1999, pp. 1-10.
2. Hiramatsu Y., Suzuki H., Kuchiki A., Nakagawa H., Fujii S. J. Pharm. Sci. 85:1996;761-766.
3. MacCalman M.L., Roberts K.J. J. Appl. Crystallogr. 28:1995;620-623.
4. DeMan J.M. Food Res. Int. 25:1992;471-476.
5. Terol A., Cassanas G., Nurit J., Pauvert B., Bouassab A., Rambaud J., Chevallet P. J. Pharm. Sci. 83:1994;1437-1442.
6. Ghodbane S., McCauley J.A. Int. J. Pharm. 59:1990;281-286.
7. Otsuka M., Kato F., Matsuda Y. Analyst. 126:2001;1578-1582.
8. Patel A.D., Luner P.E., Kemper M.S. J. Pharm. Sci. 90:2001;360-370.
9. Blanco M., Villar A. Analyst. 125:2000;2311-2314.
10. Patel A.D., Luner P.E., Kemper M.S. Int. J. Pharm. 206:2000;63-74.
11. Blanco M., Coello J., Iturriaga H., Maspoch S., Perez-Maseda C. Anal. Chim. Acta. 407:2000;247-254.
12. Cauchie P., Hubloux A., Crokaert F. Infect. Dis. Ther. 23:2000;658-663.
13. Kirchhoff R.M., Laufen H., Schacke G., Kirchhoff G., Gallo E. Int. J. Clin. Pharm. Ther. 37:1999;361-364.
14. Ghone A.K., Mehendre R.P., Tipnis H.P. Indian Drugs. 32:1995;65-68.
15. Gandhi R., Kaul C.L., Panchagnula R. J. Pharm. Biomed. Anal. 23:2000;1073-1078.
16. Raines D.A., Yusuf A., Jabak M.H., Ahmed W.S., Karcioglu Z.A., El-Yazigi A. Ther. Drug Monit. 20:1998;680-684.
17. Wigman L.S., Darrington R.T., Young J.W. J. Liq. Chromatogr. Relat. Technol. 21:1998;819-828.
18. Riedel K.D., Wildfeuer A., Laufen H., Zimmermann T. J. Chromatogr. 576:1992;358-362.
19. Shepard R.M., Duthu G.S., Ferraina R.A., Mullins M.A. J. Chromatogr. 565:1991;321-337.
20. http://www.ich.org/ich5q.html , ICH Guidelines: Q2A Text on Validation of Analytical Procedures 1994, Q2B Validation of Analytical Procedures: Methodology, 1996.